Masaki Yasukawa

6PUBLICATIONS
21CO-AUTHORS
Infectious diseasesRegenerative medicine (incl. stem cells)Cancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 22, 2021
A multicenter non-randomized, uncontrolled single arm trial for evaluation of the efficacy and the safety of the treatment with favipiravir for patients with severe fever with thrombocytopenia syndrome.

Koichiro Suemori, Masayuki Saijo, Atsushi Yamanaka

|Jan 19, 2021
A clinically applicable and scalable method to regenerate T-cells from iPSCs for off-the-shelf T-cell immunotherapy.

Shoichi Iriguchi, Yutaka Yasui, Yohei Kawai

|Sep 19, 2019
Direct comparison of target-reactivity and cross-reactivity induced by CAR- and BiTE-redirected T cells for the development of antibody-based T-cell therapy.

Masaki Maruta, Toshiki Ochi, Kazushi Tanimoto

|Jan 11, 2019
Histone H3K27 Demethylase Negatively Controls the Memory Formation of Antigen-Stimulated CD8+ T Cells.

Takeshi Yamada, Shogo Nabe, Koji Toriyama

|Aug 19, 2018
The tumor suppressor menin prevents effector CD8 T-cell dysfunction by targeting mTORC1-dependent metabolic activation.

Junpei Suzuki, Takeshi Yamada, Kazuki Inoue

|Nov 06, 2016
Menin Plays a Critical Role in the Regulation of the Antigen-Specific CD8+ T Cell Response upon Listeria Infection.

Takeshi Yamada, Makoto Kanoh, Shogo Nabe

Pageof 1

Frequent Collaborators

1 joint publications

Makoto Kanoh

1 joint publications

Toshiaki Yasuoka

1 joint publications

Takeshi Yamada

1 joint publications

Yuuki Imai